Autobio Diagnostics Co., Ltd.SSE: 603658

Announcement on Convening the Q3 2025 Performance Briefing

Nov 29, 2025 · Issued by Autobio Diagnostics Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Nov 29, 2025

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2025-performance-briefing-544

Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Autobio Diagnostics Co., Ltd. on 6ix

Earlier from Autobio Diagnostics

Announcement on Election of Employee Representative Directors for the 5th Board of DirectorsNov 15, 2025
Supplementary Announcement on Correction of Notice on the 2nd Extraordinary General Meeting in 2025Nov 7, 2025
Announcement on Revision and Formulation of Corporate Internal Governance SystemsOct 30, 2025
Announcement on Change of Sponsor RepresentativeOct 25, 2025
Announcement on Change Registration of Medical Device Business License and the Drug Business License by Wholly-owned SubsidiaryOct 14, 2025

Later from Autobio Diagnostics

Announcement on Company and Its Subsidiary Obtaining Medical Device Registration CertificateDec 3, 2025
Announcement on Using Idle Raised Funds for Cash ManagementDec 10, 2025
Announcement on Company and Its Tier-II Subsidiary Obtaining Medical Device Registration CertificateDec 31, 2025
Announcement on the Wholly-Owned Subsidiary and Secondary Subsidiary Re-certified as High-tech EnterprisesJan 1
Announcement on the Wholly-owned Subsidiary and Secondary Subsidiary Certified as High-tech EnterprisesJan 17

All Autobio Diagnostics news releases

Follow Autobio Diagnostics into a list and get an email when it puts out news.

Follow Autobio Diagnostics